Advances in stent technology and drug-eluting stents

Surgical Clinics of North America

Volumn 84, Issue 5, 2004, Pages 1203-1236

  Nelken, Nicolas ^a,b   Schneider, Peter A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 578; ALLOY; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BATIMASTAT; CARDIOVASCULAR AGENT; COBALT; DEXAMETHASONE; EVEROLIMUS; NITINOL; PACLITAXEL; PLATINUM; POLYMER; RAPAMYCIN; STAINLESS STEEL; TACROLIMUS; TANTALUM; UNCLASSIFIED DRUG;

AORTIC STENT; BIOTECHNOLOGY; CAROTID STENT; CERAMICS; CLINICAL PRACTICE; CORONARY BLOOD VESSEL; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG RELEASE; DRUG SOLUBILITY; FEMORAL POPLITEAL STENT; GEOMETRY; HUMAN; ILIAC STENT; INFRAPOPLITEAL STENT; INTIMA; MATERIAL COATING; MEDICAL RESEARCH; ONCOGENE C MYC; PRIORITY JOURNAL; PUBLISHING; RADIATION; RENAL ARTERY STENT; REVIEW; STATISTICAL SIGNIFICANCE; SURGEON; TECHNIQUE; VASCULAR DISEASE; VASCULAR PATENCY; VASCULAR SURGERY;

ANGIOPLASTY, BALLOON; ANIMALS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; EQUIPMENT DESIGN; HUMANS; STENTS; VASCULAR DISEASES;

EID: 4544342071     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2004.05.003     Document Type: Review

References (85)

1. Robertson E, Noble H, McGowan D. A composition on "stents." Available at: http://www.rcpsglasg.ac.uk/hdrg/2003Oct8.htm.
2. Dotter C.T. Transluminally-placed coilspring endarterial tube grafts. Long-term patency in canine popliteal artery. Invest Radiol. 4:(5):1969;329-332
3. Dotter C.T., Judkins M.P. Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. Circulation. 30:1964;654-670
4. Dotter C.T., Buschmann R.W., McKinney M.K., Rosch J. Transluminal expandable nitinol coil stent grafting: preliminary report. Radiology. 147:(1):1983;259-260
5. Puel J., Joffre F., Rousseau H., et al. [Self-expanding coronary endoprosthesis in the prevention of restenosis following transluminal angioplasty. Preliminary clinical study.]. Arch Mal Coeur Vaiss. 80:(8):1987;1311-1312
6. Stoeckel D., Bonsignore E., Duda S. A survey of stent designs. Min Invas Ther Allied Technol. 11:(4):2002;137-141
7. Leung D.A., Spinosa D.J., Hagspiel K.D., Angle J.F., Matsumoto A.H. Selection of stents for treating iliac arterial occlusive disease. J Vasc Interv Radiol. 14:(2 Pt 1):2003;137-152
8. Morasch M.D., Collins J., Pereles F.S., et al. Lower extremity stepping-table magnetic resonance angiography with multilevel contrast timing and segmented contrast infusion. J Vasc Surg. 37:(1):2003;62-71
9. Topol E.J. Coronary-artery stents - gauging, gorging, and gouging. N Engl J Med. 339:(23):1998;1702-1704
10. Duerig T., Tolomeo D., Wholey M. An overview of superelastic stent design. Min Invas Ther Allied Technol. 9:(3/4):2000;235-246
11. Cremonesi A., Castriota F., Manetti R., Balestra G., Liso A. Endovascular treatment of carotid atherosclerotic disease: early and late outcome in a non-selected population. Ital Heart J. 1:(12):2000;801-809
12. Gray R.J., Dolmatch B.L., Horton K.M., Romolo J.L., Zarate A.R. Migration of Palmaz stents following deployment for venous stenoses related to hemodialysis access. J Vasc Interv Radiol. 5:(1):1994;117-120
13. Trerotola S. Axillosubclavian veins and superior vena cava. Savader S., Trerotola S. Venous interventional radiology with clinical perspectives. 1996;269-284 Thieme, New York
14. Schatz R.A., Palmaz J.C., Tio F.O., Garcia F., Garcia O., Reuter S.R. Balloon-expandable intracoronary stents in the adult dog. Circulation. 76:(2):1987;450-457
15. Miura S., Yoshioka T., Furuichi K., Tanaka T., Kichikawa K., Ohishi H. [Mechanical properties of biliary metallic stents: an experimental comparison.]. Nippon Igaku Hoshasen Gakkai Zasshi. 63:(5):2003;201-209
16. Schatz R.A., Baim D.S., Leon M., Ellis S.G., Goldberg S., Hirshfeld J.W., et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation. 83:(1):1991;148-161
17. Rousseau H., Joffre J., Puel J., et al. Percutaneous vascular stent: experimental studies and preliminary clinical results in peripheral arterial diseases. Int Angiol. 6:(2):1987;153-161
18. Roubin G.S., Robinson K.A., King S.B. 3rd, et al. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation. 76:(4):1987;891-897
19. Escaned J., Goicolea J., Alfonso F., et al. Propensity and mechanisms of restenosis in different coronary stent designs: complementary value of the analysis of the luminal gain-loss relationship. J Am Coll Cardiol. 34:(5):1999;1490-1497
20. Palmaz J.C., Bailey S., Marton D., Sprague E. Influence of stent design and material composition on procedure outcome. J Vasc Surg. 36:(5):2002;1031- 1039
21. Strecker E.P., Boos I.B., Hagen B. Flexible tantalum stents for the treatment of iliac artery lesions: long-term patency, complications, and risk factors. Radiology. 199:(3):1996;641-647
22. Barth K.H., Virmani R., Froelich J., et al. Paired comparison of vascular wall reactions to almaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circulation. 93:(12):1996;2161-2169
23. vom Dahl J., Haager P.K., Grube E., et al. Effects of gold coating of coronary stents on neointimal proliferation following stent implantation. Am J Cardiol. 89:(7):2002;801-805
24. Maintz D., Kugel H., Schellhammer F., Landwehr P. In vitro evaluation of intravascular stent artifacts in three-dimensional MR angiography. Invest Radiol. 36:(4):2001;218-224
25. Riepe G., Heintz C., Kaiser E., et al. What can we learn from explanted endovascular devices? Eur J Vasc Endovasc Surg. 24:(2):2002;117-122
26. Shih C., Lin S., Chung K., Chen Y., Su Y. Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide. J Biomed Mater Res. 52:(2):2000;323-332
27. Park S.J., Lee C.W., Hong M.K., et al. Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease. Am J Cardiol. 89:(7):2002;872-875
28. Haude M., Konorza T.F., Kalnins U., et al. Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation. 107:(9):2003;1265-1270
29. Emanuelsson H., van der Giessen W.J., Serruys P.W. Benestent II: back to the future. J Interv Cardiol. 7:(6):1994;587-592
30. Atalar E., Haznedaroglu I., Aytemir K., et al. Effects of stent coating on platelets and endothelial cells after intracoronary stent implantation. Clin Cardiol. 24:(2):2001;159-164
31. Baker J., Horn J., Nikolaychik V., Kipshidze N. Fibrin stent coatings. 1996;WB Saunders, London (UK)
32. Kutryk M., Kuliszewski M.A. In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices. Am J Cardiol. 92:(6, Suppl 1):2003;. 94 L (abstract)
33. Kaiser C. Antibody-coated stents attract endothelial cells. Available at: Diagnostic Imaging Online (www.diagnosticimaging.com/dinews/2004012602.shtml). Accessed: January 26, 2004.
34. Palmaz J.C. Stents from the past, present and future. Endovasc Today. 3:2004;37-41
35. Auge B.K., Ferraro R.F., Madenjian A.R., Preminger G.M. Evaluation of a dissolvable ureteral drainage stent in a Swine model. J Urol. 168:(2):2002;808-812
36. Serruys P.W., Degertekin M., Tanabe K., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation. 106:(7):2002;798-803
37. Enger C., Wolinsky H. Porous balloon catheters. Semin Interv Cardiol. 1:(1):1996;28-29
38. Martin S.G., Murray J.C. Gene-transfer systems for human endothelial cells. stewart.martin@nottingham.ac.uk. Adv Drug Deliv Rev. 41:(2):2000;223-233
39. Clowes A.W. Regulation of smooth muscle cell proliferation and migration. Transplant Proc. 31:(1-2):1999;810-811
40. Goggins W.C., Fisher R.A., Cohen D.S., Tawes J.W., Grimes M.M. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy. J Heart Lung Transplant. 15:(8):1996;790-795
41. Sousa J.E., Costa M.A., Abizaid A.C., et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation. 104:(17):2001;2007-2011
42. Sousa J.E., Costa M.A., Sousa A.G., et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 107:(3):2003;381-383
43. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:(23):2002;1773-1780
44. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 349:(14):2003;1315-1323
45. Park S.J., Shim W.H., Ho D.S., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 348:(16):2003;1537-1545
46. Bullesfeld L., Gerckens U., Muller R., Grube E. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I. Z Kardiol. 92:(10):2003;825-832
47. Hong M.K., Mintz G.S., Lee C.W., et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation. 107:(4):2003;517-520
48. Kutryk M.J., Foley D.P., van den Brand M., et al. Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial. J Am Coll Cardiol. 39:(2):2002;281-287
49. Busch C., Cancilla P.A., DeBault L.E., Goldsmith J.C., Owen W.G. Use of endothelium cultured on microcarriers as a model for the microcirculation. Lab Invest. 47:(5):1982;498-504
50. Esmon C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 264:(9):1989;4743-4746
51. Westcott M.A., Bonn J. Comparison of conventional angioplasty with the Palmaz stent in the treatment of abdominal aortic stenoses from the STAR registry. SCVIR Transluminal Angioplasty and Revascularization. J Vasc Interv Radiol. 9:(2):1998;225-231
52. Henry M., Klonaris C., Amor M., Henry I., Tzvetanov K. State of the art: which stent for which lesion in peripheral interventions? Tex Heart Inst J. 27:(2):2000;119-126
53. Stoeckelhuber B.M., Meissner O., Stoeckelhuber M., Wiesmann M., Kueffer G. Primary endovascular stent placement for focal infrarenal aortic stenosis: initial and midterm results. J Vasc Interv Radiol. 14:(11):2003;1443-1447
54. Feugier P., Toursarkissian B., Chevalier J.M., Favre J.P. Endovascular treatment of isolated atherosclerotic stenosis of the infrarenal abdominal aorta: long-term outcome. Ann Vasc Surg. 17:(4):2003;375-385
55. Deshmukh H.L., Rathod K.R., Sheth R.J., Garg A. Fatal aortic rupture complicating stent plasty in a case of aortoarteritis. Cardiovasc Intervent Radiol. 26:(5):2003;496-498
56. Tetteroo E., van der Graaf Y., Bosch J.L., et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 351:(9110):1998;1153-1159
57. Bosch J.L., Tetteroo E., Mali W.P., Hunink M.G. Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group. Radiology. 208:(3):1998;641-648
58. Samuels S., Dake M. Extracardiac vascular interventions. Braunwald. Heart disease: a textbook of cardiovascular medicine. 6th edition:2001;1485-1503 WB Saunders, Philadelphia
59. Bosch J.L., Hunink M.G. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 204:(1):1997;87-96
60. Kauffmann G.W., Richter G.M., Noldge G., Roeren T., Landwehr P., Lackner K. [4 years' experience with a balloon-expandable endoprosthesis. Experimental and clinical application.]. Radiologe. 31:(4):1991;202-209
61. Murphy T.P., Webb M.S., Lambiase R.E., et al. Percutaneous revascularization of complex iliac artery stenoses and occlusions with use of Wallstents: three-year experience. J Vasc Interv Radiol. 7:(1):1996;21-27
62. Henry M., Amor M., Ethevenot G., et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4-year follow-up. Radiology. 197:(1):1995;167-174
63. Cejna M., Thurnher S., Illiasch H., et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 12:(1):2001;23-31
64. Price J.F., Leng G.C., Fowkes F.G. Should claudicants receive angioplasty or exercise training? Cardiovasc Surg. 5:(5):1997;463-470
65. McDaniel M.D., Cronenwett J.L. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 3:(3):1989;273-277
66. Capek P., McLean G.K., Berkowitz H.D. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation. 83:(2 Suppl):1991;I70-I80
67. Martin E.C., Katzen B.T., Benenati J.F., et al. Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol. 6:(6):1995;843-849
68. Vroegindeweij D., Vos L.D., Tielbeek A.V., Buth J., vd Bosch H.C. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Intervent Radiol. 20:(6):1997;420-425
69. Grimm J., Muller-Hulsbeck S., Jahnke T., Hilbert C., Brossmann J., Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 12:(8):2001;935-942
70. Zdanowski Z., Albrechtsson U., Lundin A., et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 18:(4):1999;251-255
71. Farrington W.J., Charnley G.J. The effect of knee flexion on the popliteal artery and its surgical significance. J Bone Joint Surg [Br]. 85:(8):2003;1208. [author reply 1208]
72. Wensing P.J., Scholten F.G., Buijs P.C., Hartkamp M.J., Mali W.P., Hillen B. Arterial tortuosity in the femoropopliteal region during knee flexion: a magnetic resonance angiographic study. J Anat. 187:(Pt 1):1995;133-139
73. Babalik E., Gulbaran M., Gurmen T., Ozturk S. Fracture of popliteal artery stents. Circ J. 67:(7):2003;643-645
74. Sacks B.A., Miller A., Gottlieb M. Fracture of an iliac artery Palmaz stent. J Vasc Interv Radiol. 7:(1):1996;53-55
75. Ansel G.M., Botti C.F. Jr., George B.S., Kazienko B.T. Clinical results for the training-phase roll-in patients in the Intracoil femoralpopliteal stent trial. Catheter Cardiovasc Interv. 56:(4):2002;443-449
76. Shetty A.A., Tindall A.J., Qureshi F., Divekar M., Fernando K.W. The effect of knee flexion on the popliteal artery and its surgical significance. J Bone Joint Surg [Br]. 85:(2):2003;218-222
77. Saxon R.R., Coffman J.M., Gooding J.M., Natuzzi E., Ponec D.J. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 14:(3):2003;303-311
78. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 106:(12):2002;1505-1509
79. Soder H.K., Manninen H.I., Jaakkola P., et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol. 11:(8):2000;1021-1031
80. Boyer L., Therre T., Garcier J.M., et al. Infrapopliteal percutaneous transluminal angioplasty for limb salvage. Acta Radiol. 41:(1):2000;73-77
81. Parsons R.E., Suggs W.D., Veith F.J., et al. Polytetrafluoroethylene bypasses to infrapopliteal arteries without cuffs or patches: a better option than amputation in patients without autologous vein. J Vasc Surg. 23:(2):1996;347-354. [discussion 355-46]
82. Dorros G., Jaff M., Mathiak L., et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 98:(7):1998;642-647
83. Rees C.R. Stents for atherosclerotic renovascular disease. J Vasc Interv Radiol. 10:(6):1999;689-705
84. Martin L.G., Rundback J.H., Sacks D., et al. Quality improvement guidelines for angiography, angioplasty, and stent placement in the diagnosis and treatment of renal artery stenosis in adults. J Vasc Interv Radiol. 14:(9 Pt 2):2003;S297-S310
85. Sos T., Trost D. Tips and tricks of RAS for high-risk patients. Endovasc Today. 2:2003;48-51